Drugs News and Research

RSS

Wake-promoting drug improves alertness in early morning shift workers

Many more people work very early morning shifts than overnight ones, and a large proportion struggle with excessive sleepiness from shift work disorder, leading to problems with focus, performance and safety.

29 Jan 2026

Combination therapy improves cognition in Alzheimer’s models

In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed medical benefits including anti-inflammatory and neuroprotective properties.

28 Jan 2026

How microalgae, fish, and krill store omega-3s differently and why it matters

This study mapped how EPA and DHA are distributed across lipid classes in microalgae, fish, krill, and commercial omega-3 supplements using lipid-class–resolved analysis. It shows that lipid structure, not just total omega-3 content, differs markedly across sources and may influence their nutritional relevance.

28 Jan 2026

Poop pills could help cancer patients respond to immunotherapy while reducing toxic side effects

Fecal microbiota transplants (FMT), can dramatically improve cancer treatment, suggest two groundbreaking studies published in the prestigious Nature Medicine journal.

28 Jan 2026

Exploring Targeted Protein Degradation as a New Strategy to Tackle Antimicrobial Resistance

Targeted protein degradation presents a promising strategy to address antimicrobial resistance, focusing on innovative approaches for gram-negative bacteria.

28 Jan 2026

New peptide targets the root causes of recurring seizures

New study suggests that an experimental peptide developed at the Hebrew University may reduce recurring seizures and support brain function by targeting underlying oxidative stress and inflammation processes linked to epilepsy.

28 Jan 2026

Antibody-producing plasma cells shape effectiveness of PD-1 immunotherapy

Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why some cancer patients benefit from immunotherapy while others do not.

27 Jan 2026

Immune system dysfunction may fuel progressive heart failure after heart attacks

When the heart's muscle is weakened or injured due to a heart attack, it can make it hard for the heart to pump enough blood to meet the body's needs.

27 Jan 2026

Insilico Medicine and Qilu Pharmaceutical partner to develop AI-designed cardiometabolic drugs

Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its subsidiary Shanghai Qilu Pharmaceutical Research Center, today announced a strategic partnership on innovative drug development, leveraging Insilico's proprietary Pharma.AI platform to jointly develop small molecule inhibitors, focusing on specific targets for cardiometabolic disease management.

27 Jan 2026

Tracking antibiotic resistance across environmental systems using advanced metagenomic tools

Antibiotic resistance is often framed as a hospital problem, but a growing body of evidence shows that the environment plays an equally critical role in the global spread of drug resistant bacteria.

27 Jan 2026

Scientists offer new insight into how common parasite T. gondii causes disease

A University of California, Riverside team of scientists has found that Toxoplasma gondii, a common parasite affecting up to one-third of the global population, is far more complex than previously believed.

27 Jan 2026

Urate-lowering gout treatment can reduce the risk of heart attack and stroke

A groundbreaking new study, led by experts at the University of Nottingham, has found that medicines used to treat gout can also reduce the risk of heart attack and stroke in people with gout.

27 Jan 2026

New role for GLP-1 drugs: Improving survival in people with severe psychiatric disorders

This editorial argues that GLP-1 receptor agonists could substantially improve healthspan and reduce premature mortality in people with serious mental illnesses by targeting cardiometabolic risk rather than psychiatric symptoms alone. It highlights emerging evidence, safety considerations, and equity challenges that position GLP-1 RAs as a promising public health strategy for this high-risk population.

25 Jan 2026

New assessment framework improves evaluation of cutaneous chronic graft-versus-host disease

An international task force of medical experts recently proposed major revisions to the way doctors measure treatment success for a common–and often severe–skin complication of stem cell transplantation.

24 Jan 2026

Dual-responsive nanodelivery system enhances immunotherapy efficacy in metastatic bladder cancer

Metastatic urothelial carcinoma has a poor prognosis: ~50% of muscle-invasive bladder cancer progresses to metastasis, and the 5-year survival for advanced/metastatic disease is <10%.

24 Jan 2026

MYC cancer gene suppresses immune alarm signals to protect pancreatic tumors

The cancer gene MYC camouflages tumors by suppressing alarm signals that normally activate the immune system.

23 Jan 2026

Why medication abortion is the top target for anti-abortion groups in 2026

This week would have marked the 53rd anniversary of Roe v. Wade, the 1973 Supreme Court decision that legalized abortion nationwide — that is, until 2022, when the court overturned it. Since then, abortion has been banned in 13 states and severely limited in 10 others.

23 Jan 2026

Genetic study links vitamin B1 metabolism to gut motility and IBS risk

Research links thiamine metabolism to gut motility, identifying genetic markers that could lead to new therapies for IBS and related digestive disorders.

23 Jan 2026

FDA warns consumers about fake cancer cures sold online

Beware of products claiming to cure cancer on websites or social media platforms, such as Facebook and Instagram. According to Nicole Kornspan, M.P.H., a consumer safety officer at the U.S. Food and Drug Administration (FDA), they're rampant these days.

22 Jan 2026

Menopausal hormone therapy linked to greater weight loss with tirzepatide

A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, a Food and Drug Administration-approved drug for the treatment of overweight and obesity.

22 Jan 2026

Previous
1
...
61
62
63
64
65
66
67
...
3024
Next

Drugs News and Research

Wake-promoting drug improves alertness in early morning shift workers

Combination therapy improves cognition in Alzheimer’s models

How microalgae, fish, and krill store omega-3s differently and why it matters

Poop pills could help cancer patients respond to immunotherapy while reducing toxic side effects

Exploring Targeted Protein Degradation as a New Strategy to Tackle Antimicrobial Resistance

New peptide targets the root causes of recurring seizures

Antibody-producing plasma cells shape effectiveness of PD-1 immunotherapy

Immune system dysfunction may fuel progressive heart failure after heart attacks

Insilico Medicine and Qilu Pharmaceutical partner to develop AI-designed cardiometabolic drugs

Tracking antibiotic resistance across environmental systems using advanced metagenomic tools

Scientists offer new insight into how common parasite T. gondii causes disease

Urate-lowering gout treatment can reduce the risk of heart attack and stroke

New role for GLP-1 drugs: Improving survival in people with severe psychiatric disorders

New assessment framework improves evaluation of cutaneous chronic graft-versus-host disease

Dual-responsive nanodelivery system enhances immunotherapy efficacy in metastatic bladder cancer

MYC cancer gene suppresses immune alarm signals to protect pancreatic tumors

Why medication abortion is the top target for anti-abortion groups in 2026

Genetic study links vitamin B1 metabolism to gut motility and IBS risk

FDA warns consumers about fake cancer cures sold online

Menopausal hormone therapy linked to greater weight loss with tirzepatide

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News